The following is a summary of “Association between the triglyceride-glucose index and liver fibrosis in adults with ...

In both clinical trials, lixudebart demonstrated a favorable safety profile, both as a monotherapy and in combination with standard of care (n=51 active patients across the two trials). These findings ...

U.S. News released its list of best diets for 2025: the low-FODMAP diet landed on top for irritable bowel syndrome and the ...

Moderate coffee consumption has been associated with improved cardiovascular health by lowering the risk of heart disease, ...

Children's Hospital Colorado (Children's Colorado) has reached a historic milestone for its Liver Transplant Program, performing a record-breaking number of transplants in 2024. With 22 liver ...

Senske Family of Companies (SFC) is proud to announce the acquisition of TurfPride, a leading provider of residential lawn care services in the Atlanta market. This strategic acquisition builds on SFC ...

Peptone, a biotech company developing novel therapeutics targeting intrinsically disordered proteins (IDPs) to treat diseases, today announced the expansion of its leadership team with the appointment ...

Madrigal Pharmaceuticals' strong launch is confirmed with impressive sales in Q1 and Q2. Learn why MDGL stock could benefit ...

Learn how stem cells from menstrual blood period blood might help treat Alzheimer’s disease A study shows how they can ...

Liver cells attempt to shut down as a defense mechanism against cancer, but this strategy is not particularly effective.

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

The advent of immunotherapy based on immune checkpoint inhibitors has improved the treatment of advanced hepatocellular ...